At KIT, we focus on highly interdisciplinary activities in the field of diagnostics and therapy ("theranostics”), We aim to revolutionize molecular diagnostic capabilities by developing new concepts, systems, and technologies that can provide the base for an affordable and robust application in clinics, point-of-care units, and homes, both in developed and developing countries. We develop strategies to overcome the outdated “organ-focused” definition of diseases by in-depth investigation of metabolomic pathways and pathogenic mechanisms to arrive at a molecular mechanism-centered disease description.

Projects

Theranostics Initiative (Bräse/ IBCS-FMS, Biedermann/INT, Feldmann/AOC, Schepers/IFG, Orian-Rousseau/ IBCS-FMS, Levkin/ IBCS-FMS, Luy/ IBG-4, Muhle-Goll/IBG-4, Korvink/ IMT)

Intelligent sensors and  wearables to track and analyse users behaviour in the mobility system (Knoch, MoBiSys/ Gauterin, Institute 2)

Microfluidic point-of-care biosensors (Dominguez, Niemeyer, Rabe/ IBG1)

Developing new molecular entities, smart materials, miniaturized high content screening methods as well as design of novel biomedical tools for the treatment of diseases (Bräse/ IOC, IBCS-FMS)

Multidiagnosis (Breitling, Mager, Weber/IMT Terzides Entechnon)

Synthetic receptors (SRs) and novel assays for the continous and rapid detection of biomarkers in biofluids (Biedermann, DeCola/IFG)

Quantifying lung perfusion parameters (Nestler/ INT, Koeppe)

Measuring the drug concentrations in blood or plasma, or in other biological fluids that can be linked to blood drug concentrations (Ates/ ITS)

Simultaneous release and monitoring of drug cocktail for effective reduction of resistances and metastases of tumors (Feldmann/ AOC, Schepers/ IFG, Bräse/ IOC)

Advanced inorganic nanocrystals for short wavelength infrared imaging and alpha radiotherapy (Hudry/ IMT, Richards/ IMT, Orian-Rousseau/ IBCS-FMS)

Parallelized Diagnostics (Orian-Roussau/ IBCS-FMS, Nesterov-Müller, IMT)

Organ-specific drug transport (Schepers/IFG, Feldmann/ AOC, Bräse/ IOC)

Identification of markers or marker patterns for civilization diseases Organ-specific drug transport (Luy, Muhle-Goll/ IBG-4)

People

people rf7
Contact
Name Title E-Mail
Prof. Dr. armin grunwald does-not-exist.kit edu
Priv.-Doz. Dr.-Ing axel loewe does-not-exist.kit edu
Prof. Dr. britta nestler does-not-exist.kit edu
Prof. Dr. bryce richards does-not-exist.kit edu
Prof. Dr. burkhard luy does-not-exist.kit edu
Dr. carmen dominguez does-not-exist.kit edu
Priv.-Doz. Dr. claudia muhle-goll does-not-exist.kit edu
Prof. Dr. claus feldmann does-not-exist.kit edu
Prof. Dr. clemens heske does-not-exist.kit edu
Dr. damien hudry does-not-exist.kit edu
Dipl.-Ing. eva-maria knoch does-not-exist.kit edu
Dr. frank biedermann does-not-exist.kit edu
Prof. Dr. frank breitling does-not-exist.kit edu
Prof. Dr. horst geckeis does-not-exist.kit edu
Prof. Dr. jan korvink does-not-exist.kit edu
Prof. Dr. luisa cola does-not-exist.kit edu
Prof. Dr. markus klute does-not-exist.kit edu
apl.-Prof. Dr. matthias franzreb does-not-exist.kit edu
Prof. Dr. matthieu letacon does-not-exist.kit edu
Prof. Dr. pavel levkin does-not-exist.kit edu
Prof. Dr. roesky does-not-exist.kit edu
Prof. Dr. stefan braese does-not-exist.kit edu
Dr. tonya vitova does-not-exist.kit edu
Prof. Dr. ute schepers does-not-exist.kit edu
Prof. Dr. veronique orian-rousseau does-not-exist.kit edu